NRNP 6635 The Psychiatric Evaluation and Evidence-Based Rating Scales

NRNP 6635 The Psychiatric Evaluation and Evidence-Based Rating Scales

NRNP 6635 The Psychiatric Evaluation and Evidence-Based Rating Scales

The psychiatric interview comprises three crucial elements: the chief complaint, psychiatric history, and mental status examination (Gao et al., 2020). Including these elements is imperative for a thorough evaluation and determination of diagnosis, furnishing significant insights for developing treatment strategies.

First, the chief complaint allows the individual to articulate their principal apprehension or motive for pursuing psychiatric assessment. Gathering chief complaints concentrates the evaluation and directs subsequent inquiry, ensuring that the healthcare provider attends to the most urgent matters.

Secondly, obtaining a thorough psychiatric history is crucial in comprehending the patient’s background, prior mental health diagnoses, treatments, and psychosocial determinants (Gao et al., 2020). This aids in the identification of prior psychiatric episodes, familial history of mental illness, substance abuse, or traumatic events. Using psychiatric history is crucial in developing an accurate diagnosis, devising a suitable treatment plan, and identifying possible risk factors or contraindications.

Finally, the Mental Status Examination (MSE) assesses the individual’s present cognitive, emotional, and behavioral performance (Dietrich & Tamas, 2020). The assessment evaluates various aspects of the individual’s presentation, including their physical appearance, verbal communication, cognitive functioning, emotional state, perceptual experiences, and level of self-awareness. The Mental Status Examination (MSE) furnishes impartial information regarding the patient’s mental condition, thereby assisting in distinguishing between various diagnoses and tracking alterations in the patient’s condition over a period. This aids healthcare professionals in evaluating the magnitude of symptoms, ascertaining the degree of functional impairment, and pinpointing any particular areas of interest.

Regarding the psychometric characteristics of the designated rating scale, the Beck Depression Inventory (BDI) is a frequently employed self-report survey instrument utilized for evaluating the intensity of depressive symptoms. According to Georgi (2019), the Beck Depression Inventory (BDI) exhibits good internal consistency and test-retest reliability, indicating high levels of reliability and validity. The assessment tool comprises a total of 21 distinct indicators that correspond to particular manifestations of depression. These indicators are evaluated using a four-point Likert scale. The aggregate score indicates the gravity of depressive symptoms, encompassing a spectrum from mild to severe depression.

Click here to ORDER an A++ paper from our Verified MASTERS and DOCTORATE WRITERS: NRNP 6635 The Psychiatric Evaluation and Evidence-Based Rating Scales

The Beck Depression Inventory (BDI) is a suitable tool to employ in a psychiatric interview to evaluate indications of

NRNP 6635 The Psychiatric Evaluation and Evidence-Based Rating Scales
NRNP 6635 The Psychiatric Evaluation and Evidence-Based Rating Scales

depression in clients. The utilization of screening tools can aid in the detection of depression, facilitate the monitoring of treatment efficacy, and enable the evaluation of responses to interventions. The utilization of a scale in psychiatric assessment is of great assistance to nursing practitioners, specifically in evaluating depressive symptoms. This is because it provides a standardized measure, which enables a quantifiable assessment of the severity and impact of depression on the patient’s daily functioning. This data can provide direction for treatment decisions, assist in formulating treatment objectives, and monitor alterations in symptomatology across time.

To sum up, the primary grievance, psychiatric background, and mental state assessment are integral elements of the psychiatric assessment. The provided information offers a comprehensive comprehension of the patient’s present issues, history, and psychological condition. The Beck Depression Inventory (BDI) is a dependable and accurate assessment tool that can be employed during clinical interviews to evaluate the intensity of depressive symptoms. The Beck Depression Inventory (BDI) is a valuable tool for nurse practitioners to assess depressive symptoms, track treatment efficacy, and support informed decision-making in treating individuals with depression.



Georgi, H. S., Vlckova, K. H., Lukavsky, J., Kopecek, M., & Bares, M. (2019). Beck Depression Inventory-II: Self-report or interview-based administrations show different results in older persons. International Psychogeriatrics31(5), 735-742. Beck Depression Inventory-II: Self-report or interview-based administrations show different results in older persons | International Psychogeriatrics | Cambridge Core

Links to an external site.

Gao, L., Xie, Y., Jia, C., & Wang, W. (2020). Prevalence of depression among Chinese university students: a systematic review and meta-analysis. Scientific reports10(1), 1-11.

Links to an external site.

Dietrich, Z. C., & Tamas, R. L. (2020). Mental status Examination. Psychiatry Morning Report: Beyond the Pearls E-Book, 9. Psychiatry Morning Report: Beyond the Pearls – Tammy Duong, Rebecca L. Tamas, Peter Ureste – Google Books

Your discussion post was very insightful. However, you need to capture the psychometric properties of the BDI-II adequately. The BDI-II has good psychometric properties. First, it has strong internal consistency with high Cronbach’s alpha values ranging from 0.89 to 0.94 (García-Batista et al., 2018). Second, it has excellent test-retest reliability over 1 to 2 weeks. Studies show correlation coefficients ranging from 0.73 to 0.96 (García-Batista et al., 2018). Third, it has good convergent and divergent validity. It has demonstrated strong positive correlations with other measures of depression, such as the Hamilton Depression Rating Scale and weaker correlations with measures of unrelated constructs, such as stress and anxiety scales (García-Batista et al., 2018). Fourth, it is highly sensitive and specific to depression. Studies indicate high sensitivity values (0.80 to 0.86) and specificity values (0.76 to 0.94) compared to diagnostic interviews conducted by mental health professionals (Park et al., 2020). Lastly, the original two-factor cognitive-affective and somatic-vegetative structure proposed by Beck has been supported in several factor analytic studies (Park et al., 2020). However, researchers have also suggested alternative factor structures such as the three-factor structure (cognitive, affective, and somatic) and hierarchical model (Park et al., 2020).


García-Batista, Z. E., Guerra-Peña, K., Cano-Vindel, A., Herrera-Martínez, S. X., & Medrano, L. A. (2018). Validity and reliability of the Beck Depression Inventory (BDI-II) in general and hospital population of Dominican Republic. PLOS ONE13(6), e0199750.

Links to an external site.

Park, K., Jaekal, E., Yoon, S., Lee, S., & Choi, K. (2020). Diagnostic utility and psychometric properties of the Beck depression Inventory-II among Korean adults. Frontiers in Psychology10

The Beck Depression Inventory (BDI) is a 21-question self-report questionnaire used to measure the symptoms of depression in an individual. This tool can be used by the individual or by the Clinician to assess to level of depression.

According to the literature this tool is one of the most widely used to assess depression. There have been tests and retests to verify reliability and validity. A second version of the BDI was developed in 1996 to align with the DSM-IV, BDI-II. Even though adequate test–retest reliability has been established with the BDI-II in older adult patients and nonpatient populations, there has been questions about the potential for overstating symptoms causing the result of the assessment to be skewed, this concern is related to the fact that the tool can be self-administered.

Wang and Gorenstein expressed their concern when they stated, “BDI-II presents the same problems as other self-applicable inventories, in which the score can be easily exaggerated, minimized or even falsified by the respondents” (2021)

In my opinion the patients ability to overstate symptoms is present in every interview and should not be the major concern in an assessment tool that would be overstated whether being self-administered or done by a Clinician.


Wang, Y.P,  Gorenstein,C.(2021) The Beck depression inventory: Uses and applications

Links to an external site.: The Neuroscience of Depression

Links to an external site..

Using the Beck Depression Inventory (BDI), people are frequently evaluated for depression-related symptoms. The BDI provides a systematic technique for evaluating depressive symptoms, enabling an accurate and consistent assessment of the severity of the condition (Upton, 2020).  By establishing baseline data, the outcomes may be followed throughout time and compared between patients. Because it can be completed quickly, a brief questionnaire like the BDI is a great tool for busy healthcare settings. Along with being effective, its briefness makes it simple for an APRN to incorporate into her workflow.

The BDI has undergone extensive testing and validation, and it has been found to have high reliability and validity when evaluating depressive symptoms. It is a reliable assessment instrument with test-retest reliability and internal consistency. The BDI is sensitive to changes in depressed symptoms in addition to tracking the success of therapeutic measures (Upton, 2020). By giving the BDI at various intervals, a nurse can establish if a patient’s depressive symptoms have gotten better, worse, or are staying the same. Patients can self-report their symptoms on BDI surveys, which can make them more engaged in their own care. By giving patients a chance to reflect on their experiences and express their thoughts, this helps the APRN and patient have a therapeutic conversation.


Upton, J. (2020). Beck depression inventory (BDI). Encyclopedia of behavioral medicine, 202-203. DOI: 10.1007/978-3-030-39903-0_441